ARS Pharmaceuticals share price logo

ARS Pharmaceuticals

NASDAQ: SPRY

Small Cap

$3.65

-0.08

(-2.14%)

as on

ARS Pharmaceuticals Stock Performance

as on October 29, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $3.52
    $3.73
    downward going graph

    3.56%

    Downside

    2.19%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.53
    $13.15
    downward going graph

    3.42%

    Downside

    260.27%

    Upside

    downward going graph

ARS Pharmaceuticals share price movements today

Previous Close
$3.73
Open
$3.65
Volume
2.5M
Market Cap
$363.0M
Day's Low - High
$3.52 - $3.73
52 Week Low - High
$3.53 - $13.15

ARS Pharmaceuticals Historical Returns

1 Month Return
-17.05 %
3 Month Return
-37.39 %
1 Year Return
-59.35 %
3 Year Return
+ 5.19 %
5 Year Return
0 %

ARS Pharmaceuticals Stock Fundamentals & Key Indicators

Check ARS Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$363.0M

EPS (TTM)

-2.18

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.71

Industry PE ratio

-8.21

PEG Ratio

0.02

EBITDA

-207.0M

Revenue (TTM)

116.9M

Profit Margin

73.89%

Return On Equity TTM

-256.67%

ARS Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ARS Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$363.0MNA-1.7173.89%0.00%
Neutral$83.0B-37.96%-26.06-12.57%0.00%
StrongBuy$132.1B186.43%30.0886.04%0.00%
Buy$84.0B27.09%19.4984.86%0.45%

Stock Returns calculator for ARS Pharmaceuticals Stock including INR - Dollar returns

The ARS Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

ARS Pharmaceuticals investment value today

Current value as on today

₹43,878

Returns

-₹56,122

(-56.12%)

Returns from ARS Pharmaceuticals Stock

-₹59,354 (-59.35%)

Dollar Impact

₹3,232 (+3.23%)

Analyst Recommendation on ARS Pharmaceuticals Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for ARS Pharmaceuticals. Average target price of $24.33

ARS Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on ARS Pharmaceuticals.

What analysts predicted

85%UPSIDE

Target Price

$24.33

Current Price

$3.65

Analyzed by

1 Analysts

High

$30

Target

$24.33

Low

$30

ARS Pharmaceuticals target price $24.33, a slight upside of 85% compared to current price of $3.65. According to 1 analysts rating.

Indian Investors' Interest in ARS Pharmaceuticals Stock

Search interest for ARS Pharmaceuticals Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-34% versus previous 30 day period

ARS Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
0
2
86
7
15
32
28
22
33
Gross Profit
-5
-6
1
82
3
10
24
24
16
20
Operating Income
-13
-15
-21
47
-37
-47
-53
-41
-60
-61
EBITDA
-10
-12
-19
50
-33
-44
-48
-40
-57
-59
Interest Expense
-
-
-
-
-
-
-
-
2
2
Depreciation
0
0
0
0
0
0
2
0
0
0
Income Before Tax
-10
-12
-19
50
-33
-44
-51
-41
-60
-62
Income Tax Expense
-
-
-
0
-
-
-
0
-
-
Net Income
-10
-12
-19
49
-33
-44
-51
-41
-60
-62
Net Profit Margin
0.00%
100.00%
94.58%
95.50%
49.25%
68.29%
74.80%
88.60%
72.29%
61.83%

ARS Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
17
5
1
0
89
84
Gross Profit
-1
-1
3
5
-15
0
68
63
Operating Income
-18
-24
0
-19
-35
-67
-3
-179
EBITDA
-16
-22
0
-19
-34
-54
8
-167
Interest Expense
-
-
0
0
-
-
-
2
Depreciation
1
1
0
0
0
0
0
1
Income Before Tax
-17
-23
-1
-20
-34
-54
8
-171
Income Tax Expense
-
-
-
-
-
-
0
0
Net Income
-17
-23
-1
-20
-34
-54
7
-171
Net Profit Margin
0.00%
0.00%
21.11%
96.13%
100.00%
100.00%
76.94%
75.77%

ARS Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-10
-12
-19
49
-33
-44
-51
-41
-60
-62
Operating Cash Flow
-6
-7
-14
42
-40
-39
-47
-43
-44
-60
Investing Cash Flow
-8
-12
16
-101
29
48
-44
24
27
41
Financing Cash Flow
0
0
0
70
0
2
100
1
0
3
Change in Cash
-14
-19
3
11
-10
11
8
-18
-16
-16

ARS Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-23
-1
-20
-34
-54
7
-171
Operating Cash Flow
-16
-18
9
-17
-40
-59
13
-170
Investing Cash Flow
0
0
0
0
0
-87
-106
56
Financing Cash Flow
19
8
5
53
190
6
72
104
Change in Cash
2
-10
14
35
150
-139
-20
-9

Global Institutional Holdings in ARS Pharmaceuticals

Check out the Institutions with significant holdings in ARS Pharmaceuticals.

Funds
Holdings
Peter Kolchinsky
10.92%
James E. Flynn
7.55%
iShares
3.07%
Vanguard
3.04%
SPDR
2.58%

ARS Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 20 August

    Fri, 01:56 AM

    -

    ARS Pharmaceuticals holder plans to sell 25,000 shares after recent sales of 100,000 shares.

Insights on ARS Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 22.68M → 33.65M (in $), with an average increase of 32.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 197.8% return, outperforming this stock by 192.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 767.1% return, outperforming this stock by 826.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -41.32M → -62.33M (in $), with an average decrease of 24.8% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SPRY stock has moved down by -15.5%

About ARS Pharmaceuticals

ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.
OrganisationARS Pharmaceuticals
Headquarters11682 El Camino Real, San Diego, CA, 92130, US
IndustryBiotechnology
CEODonn Casale

Key Management of ARS Pharmaceuticals

Name

Title

Mr. Justin Chakma

Chief Business Officer

Mr. Donn Casale

CEO, President & Director

Ms. Lynda Harris

Vice President of Human Resources

Mr. Eric Karas

Chief Commercial Officer

Dr. Robert Bell Ph.D.

Co-Founder & Chief Science Officer

Ms. Kathleen D. Scott CPA

Chief Financial Officer

Mr. Brian T. Dorsey M.S.

Chief Operating Officer

Mr. Alexander A. Fitzpatrick Esq.

Chief Legal Officer & Secretary

Mr. Daniel Relovsky

Senior Vice President of Marketing

FAQs

What is ARS Pharmaceuticals share price today?

ARS Pharmaceuticals share price today is $3.65 as on at the close of the market. ARS Pharmaceuticals share today touched a day high of $3.73 and a low of $3.52.

What is the 52 week high and 52 week low for ARS Pharmaceuticals share?

ARS Pharmaceuticals share touched a 52 week high of $13.15 on and a 52 week low of $3.53 on . ARS Pharmaceuticals stock price today i.e. is closed at $3.65,which is 72.24% down from its 52 week high and 3.55% up from its 52 week low.

What is ARS Pharmaceuticals's market capitalisation today?

ARS Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in ARS Pharmaceuticals Stock (SPRY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ARS Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy ARS Pharmaceuticals Stock (SPRY) from India?

Indian investors can start investing in ARS Pharmaceuticals (SPRY) shares with as little as ₹95.25 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.50 in ARS Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on ARS Pharmaceuticals share’s latest price of $3.65 as on October 29, 2026 at 8:46 am IST, you will get 2.7397 shares of ARS Pharmaceuticals. Learn more about fractional shares .